双荧光素酶报告基因实验详细流程

## 一、实验准备阶段

1. **质粒构建**
   - **启动子-荧光素酶报告载体构建**
     * PCR扩增目标基因启动子区域(通常为转录起始位点上游1-2kb)
     * 酶切消化PCR产物和pGL4.10载体(含有萤火虫荧光素酶基因但无启动子)
     * 连接反应将启动子片段插入载体
     * 转化大肠杆菌DH5α
     * 挑取单克隆进行小量提取和测序验证
     * 大量提取质粒并测定浓度和纯度

   - **转录元件(TE)表达载体构建**
     * PCR扩增TE编码序列
     * 将序列克隆至表达载体(如pcDNA3.1)中
     * 转化、验证和提取质粒同上

   - **对照载体准备**
     * pRL-TK载体(含有海肾荧光素酶基因,用于内参)
     * 空载体(不含TE序列的表达载体)
     * 阳性对照(已知强启动子如CMV驱动的荧光素酶载体)

2. **细胞培养准备**
   - 选择合适细胞系(如HEK293T或与目标基因表达组织相关的细胞)
   - 细胞复苏和传代
   - 细胞鉴定和支原体检测
   - 优化转染条件(试验最佳细胞密度和转染试剂比例)

## 二、转染实验

1. **实验分组**
   - 测试组:启动子-萤火虫荧光素酶载体 + TE表达载体 + pRL-TK
   - 阴性对照1:启动子-萤火虫荧光素酶载体 + 空表达载体 + pRL-TK
   - 阴性对照2:无启动子萤火虫荧光素酶载体 + TE表达载体 + pRL-TK
   - 阳性对照:已知活性启动子-萤火虫荧光素酶载体 + pRL-TK

2. **细胞接种**
   - 计数细胞并调整至适当浓度
   - 在24孔板中接种细胞(通常1-2×10^5细胞/孔)
   - 培养至70-80%融合度(通常24小时)

3. **转染操作**
   - 准备转染混合物:
     * 每孔450ng启动子-萤火虫荧光素酶载体
     * 450ng TE表达载体或空载体
     * 100ng pRL-TK载体
     * 适量转染试剂(如Lipofectamine 2000)
   - 按照试剂说明书进行转染
   - 每组设置3个技术重复孔
   - 转染后更换为完全培养基

4. **转染后培养**
   - 转染后24-48小时收获细胞(根据蛋白表达动力学确定最佳时间)
   - 期间可取少量细胞进行Western blot验证TE蛋白表达

## 三、荧光素酶活性检测

1. **样品制备**
   - 弃去培养基,PBS洗涤细胞
   - 加入适量细胞裂解缓冲液(如Passive Lysis Buffer)
   - 室温震荡裂解10-15分钟
   - 收集裂解液至离心管
   - 离心去除细胞碎片(12,000g, 2分钟)
   - 取上清液进行检测

2. **双荧光素酶活性测定**
   - 使用双荧光素酶报告基因检测系统(Promega)
   - 向20μl细胞裂解液中加入100μl萤火虫荧光素酶底物
   - 立即在发光检测仪上测量萤火虫荧光素酶活性(2秒积分时间)
   - 加入100μl海肾荧光素酶底物(Stop & Glo试剂)
   - 立即测量海肾荧光素酶活性(2秒积分时间)

3. **平行验证实验**
   - **Western blot**:
     * 收获部分转染细胞裂解提取蛋白
     * SDS-PAGE分离蛋白
     * 转膜、封闭、孵育抗体
     * 检测TE蛋白表达水平和内参蛋白(如GAPDH)
   
   - **RT-qPCR**:
     * 提取转染细胞总RNA
     * 反转录合成cDNA
     * 实时定量PCR检测萤火虫荧光素酶mRNA水平
     * 与内参基因相对定量

## 四、数据分析

1. **数据标准化**
   - 计算每个样品的萤火虫/海肾荧光素酶活性比值(F/R)
   - 标准化消除转染效率差异影响

2. **相对活性计算**
   - 计算测试组相对于阴性对照1的活性倍数变化
   - 公式:测试组F/R ÷ 阴性对照F/R

3. **统计分析**
   - 计算每组3个独立生物学重复的平均值和标准差/标准误
   - 使用Student's t检验或ANOVA分析组间差异显著性
   - 通常p<0.05被认为具有统计学意义

4. **图表制作**
   - 绘制柱状图显示各组相对荧光素酶活性
   - 误差线表示标准差或标准误
   - 标注统计显著性(*p<0.05, **p<0.01, ***p<0.001)
   - 包括单独数据点增加透明度

## 五、结果验证与扩展

1. **突变体分析**
   - 设计启动子区域潜在结合位点的点突变体
   - 重复荧光素酶实验验证关键结合位点

2. **剂量依赖性分析**
   - 使用不同量的TE表达载体(如100ng, 300ng, 900ng)
   - 检测启动子活性与TE表达量的关系

3. **辅助验证实验**
   - **染色质免疫沉淀(ChIP)**验证TE与启动子的物理结合
   - **电泳迁移率变动实验(EMSA)**确认直接DNA-蛋白相互作用
   - 在不同细胞系中重复实验验证调控关系的普遍性

---- 

# Detailed Protocol for Dual-Luciferase Reporter Assay

## I. Preparatory Phase

1. **Plasmid Construction**
   - **Promoter-Luciferase Reporter Vector Construction**
     * PCR amplify target gene promoter region (typically 1-2kb upstream of TSS)
     * Digest PCR product and pGL4.10 vector (containing firefly luciferase gene without promoter) with appropriate restriction enzymes
     * Ligate promoter fragment into vector
     * Transform into E. coli DH5α
     * Pick single colonies for miniprep and sequence verification
     * Perform maxiprep and determine concentration and purity

   - **Transcription Element (TE) Expression Vector Construction**
     * PCR amplify TE coding sequence
     * Clone sequence into expression vector (e.g., pcDNA3.1)
     * Transform, verify, and extract plasmid as above

   - **Control Vector Preparation**
     * pRL-TK vector (containing Renilla luciferase gene, for internal control)
     * Empty vector (expression vector without TE sequence)
     * Positive control (known strong promoter such as CMV driving luciferase)

2. **Cell Culture Preparation**
   - Select appropriate cell line (e.g., HEK293T or tissue-relevant cell line)
   - Thaw and passage cells
   - Authenticate cell line and test for mycoplasma
   - Optimize transfection conditions (test optimal cell density and transfection reagent ratios)

## II. Transfection Experiment

1. **Experimental Groups**
   - Test group: Promoter-firefly luciferase vector + TE expression vector + pRL-TK
   - Negative control 1: Promoter-firefly luciferase vector + Empty expression vector + pRL-TK
   - Negative control 2: Promoterless firefly luciferase vector + TE expression vector + pRL-TK
   - Positive control: Known active promoter-firefly luciferase vector + pRL-TK

2. **Cell Seeding**
   - Count cells and adjust to appropriate concentration
   - Seed cells in 24-well plates (typically 1-2×10^5 cells/well)
   - Culture until 70-80% confluent (typically 24 hours)

3. **Transfection Procedure**
   - Prepare transfection mixture:
     * 450ng promoter-firefly luciferase vector per well
     * 450ng TE expression vector or empty vector
     * 100ng pRL-TK vector
     * Appropriate amount of transfection reagent (e.g., Lipofectamine 2000)
   - Perform transfection according to reagent protocol
   - Set up 3 technical replicate wells per group
   - Replace with complete culture medium after transfection

4. **Post-Transfection Culture**
   - Harvest cells 24-48 hours post-transfection (determine optimal time based on protein expression kinetics)
   - Optionally take a small aliquot of cells for Western blot to verify TE protein expression

## III. Luciferase Activity Detection

1. **Sample Preparation**
   - Remove culture medium, wash cells with PBS
   - Add appropriate volume of cell lysis buffer (e.g., Passive Lysis Buffer)
   - Shake at room temperature for 10-15 minutes to lyse cells
   - Collect lysate into centrifuge tubes
   - Centrifuge to remove cell debris (12,000g, 2 minutes)
   - Transfer supernatant for detection

2. **Dual-Luciferase Activity Measurement**
   - Use Dual-Luciferase Reporter Assay System (Promega)
   - Add 100μl of firefly luciferase substrate to 20μl cell lysate
   - Immediately measure firefly luciferase activity on a luminometer (2-second integration time)
   - Add 100μl of Renilla luciferase substrate (Stop & Glo reagent)
   - Immediately measure Renilla luciferase activity (2-second integration time)

3. **Parallel Validation Experiments**
   - **Western Blot**:
     * Harvest a portion of transfected cells for protein extraction
     * Separate proteins by SDS-PAGE
     * Transfer to membrane, block, and incubate with antibodies
     * Detect TE protein expression and reference protein (e.g., GAPDH)
   
   - **RT-qPCR**:
     * Extract total RNA from transfected cells
     * Reverse transcribe to cDNA
     * Perform real-time quantitative PCR to detect firefly luciferase mRNA levels
     * Quantify relative to reference gene

## IV. Data Analysis

1. **Data Normalization**
   - Calculate firefly/Renilla luciferase activity ratio (F/R) for each sample
   - Normalization eliminates variations in transfection efficiency

2. **Relative Activity Calculation**
   - Calculate fold change in activity of test group relative to negative control 1
   - Formula: Test group F/R ÷ Negative control F/R

3. **Statistical Analysis**
   - Calculate mean and standard deviation/SEM from 3 independent biological replicates
   - Perform Student's t-test or ANOVA to analyze significance between groups
   - Typically p<0.05 is considered statistically significant

4. **Figure Preparation**
   - Create bar graphs showing relative luciferase activity for each group
   - Error bars represent standard deviation or SEM
   - Indicate statistical significance (*p<0.05, **p<0.01, ***p<0.001)
   - Include individual data points for transparency

## V. Result Validation and Extension

1. **Mutant Analysis**
   - Design point mutations in potential binding sites within the promoter region
   - Repeat luciferase assay to validate critical binding sites

2. **Dose-Dependency Analysis**
   - Use varying amounts of TE expression vector (e.g., 100ng, 300ng, 900ng)
   - Detect relationship between promoter activity and TE expression level

3. **Supplementary Validation Experiments**
   - **Chromatin Immunoprecipitation (ChIP)** to verify physical interaction between TE and promoter
   - **Electrophoretic Mobility Shift Assay (EMSA)** to confirm direct DNA-protein interaction
   - Repeat experiments in different cell lines to validate the universality of the regulatory relationship

This detailed protocol helps researchers systematically evaluate the regulatory effect of specific transcription elements on target gene promoters.

-----

## 1. Experimental Purpose
- **Scientific Question**: Does a specific transcription element (TE) directly regulate gene expression through interaction with a target promoter?
- **Design Rationale**: The dual-luciferase reporter assay provides a quantitative measure of promoter activity with and without the TE of interest, allowing direct assessment of functional regulatory relationships.
- **Follow-up Studies**: Additional experiments could examine dose-dependency, test multiple TEs, or investigate the effect in different cell types to establish biological relevance and specificity.

## 2. Model System
- **Primary System**: Human cell lines relevant to the gene's function (e.g., HEK293T for general studies, or tissue-specific lines like HepG2 for liver-expressed genes)
- **Rationale**: Cell culture provides a controlled environment to isolate the specific TE-promoter interaction while maintaining human genomic context
- **Alternatives**:
  - In vivo mouse models (pros: physiological context; cons: complex, expensive, species differences)
  - In vitro binding assays (pros: direct biochemical evidence; cons: lacks cellular context)
  - Yeast one-hybrid (pros: high-throughput; cons: non-mammalian transcriptional machinery)
- **Ethical Considerations**: Cell line authentication, mycoplasma testing, and proper documentation of cell line origin

## 3. Measurement Approach
- **Techniques**:
  - Dual-luciferase reporter assay (quantitative)
  - Western blot to confirm TE protein expression
  - RT-qPCR to verify mRNA levels
- **Technical Replicates**: Triplicate measurements for each biological sample
- **Potential Biases**:
  - Transfection efficiency variations (minimized by dual-reporter normalization)
  - Plasmid preparation quality (controlled by using same preparation batch)
  - Cell density and passage number effects (standardized seeding and culture conditions)

## 4. Group Setting
- **Experimental Groups**:
  - Test condition: Cells co-transfected with TE expression vector + promoter-firefly luciferase construct + Renilla control
  - Negative control 1: Empty expression vector + promoter-firefly luciferase construct + Renilla control
  - Negative control 2: TE expression vector + promoterless luciferase construct + Renilla control
  - Positive control: Known active promoter-luciferase construct + Renilla control
- **Controlled Variables**: Cell density, passage number, transfection reagent lot, incubation time
- **Biological Replicates**: Minimum 3 independent experiments with fresh transfections
- **Modified Design**: Include multiple promoter fragments of varying lengths to map the precise TE binding region

## 5. Data Analysis & Presentation
- **Data Processing**: 
  - Raw luminescence values normalized (firefly/Renilla ratio)
  - Fold-change calculated relative to negative control
- **Statistical Analysis**:
  - Student's t-test or ANOVA with post-hoc tests depending on group numbers
  - Sample size determined by power analysis (typically n=3-6 is sufficient for cell culture)
- **Data Presentation**:
  - Bar graphs showing normalized luciferase activity with error bars (SEM or SD)
  - Include individual data points for transparency
- **Validation Methods**:
  - ChIP assay to confirm physical binding of TE to the promoter region
  - EMSA to verify direct DNA-protein interaction
  - Mutational analysis of putative binding sites in the promoter